Anti-cancer Therapies in High Grade Gliomas

By  

Current Proteomics, Vol. 10, Iss. 3, 2013-01 ,pp. : 246-260

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family

By Goldin Natalia   Heyfets Alina   Reischer Dorit   Flescher Eliezer  

Journal of Bioenergetics and Biomembranes, Vol. 39, Iss. 1, 2007-02 ,pp. : 51-57

Springer Publishing Company

Access to resources Recommend Favorite

Anti-angiogenic therapies in prostate cancer

By Martínez-Jabaloyas José María   March-Villalba José Antonio   Navarro-García María Mercedes   Dasi Francisco  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 1, 2013-01 ,pp. : 1-5

Informa Healthcare

Access to resources Recommend Favorite

Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II

By Neuzil Jiri   Dyason Jeffrey   Freeman Ruth   Dong Lan-Feng   Prochazka Lubomir   Wang Xiu-Fang   Scheffler Immo   Ralph Stephen  

Journal of Bioenergetics and Biomembranes, Vol. 39, Iss. 1, 2007-02 ,pp. : 65-72

Springer Publishing Company

Access to resources Recommend Favorite

Photodynamic anti-cancer effects of fullerene [C₆₀]–PEG complex on fibrosarcomas preferentially over normal fibroblasts in terms of fullerene uptake and cytotoxicity

By Asada Ryoko   Liao Feng   Saitoh Yasukazu   Miwa Nobuhiko  

Molecular and Cellular Biochemistry, Vol. 390, Iss. 1-2, 2014-05 ,pp. : 175-184

Springer Publishing Company

Access to resources Recommend Favorite